Ian Pitfield
Chief Tech/Sci/R&D Officer chez GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profil
Ian Pitfield is a professional who has worked as the Head of Cell & Gene Therapy Medicine at GSK Plc from 1993 to 2016.
Currently, he is the Senior Vice President-Technical Operations at Gyroscope Therapeutics Holdings Plc since 2020.
Dr. Pitfield holds a doctorate degree from the University of Cambridge.
Postes actifs de Ian Pitfield
| Sociétés | Poste | Début |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/07/2020 |
Anciens postes connus de Ian Pitfield
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/12/2016 |
Formation de Ian Pitfield
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
